No Added Value of Novel Biomarkers in the Diagnostic Assessment of Patients Suspected of Acute Coronary Syndrome

BACKGROUND: Despite the availability of high-sensitive troponin (hs-cTnT), there is still room for improvement in the diagnostic assessment of patients suspected of acute coronary syndrome (ACS). Apart from serial biomarker testing, which is time-consuming, novel biomarkers like copeptin have been p...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:PLoS One
Autores principales: Poldervaart, Judith M., Röttger, Emma, Dekker, Marieke S., Zuithoff, Nicolaas P. A., Verheggen, Peter W. H. M., de Vrey, Evelyn A., Wildbergh, Thierry X., van ‘t Hof, Arnoud W. J., Mosterd, Arend, Hoes, Arno W.
Formato: Artigo
Lenguaje:Inglês
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4503345/
https://ncbi.nlm.nih.gov/pubmed/26177390
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0132000
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares